News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Novo Holdings A/S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Bought 2,469,135 shares
@ $2.025, valued at
$5M
Bought 2,469,135 warrants
@ $2.47, valued at
$6.1M
|
|
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 11,000 shares
@ $2.7365, valued at
$30.1k
Sold 21,100 shares
@ $2.7488, valued at
$58k
Sold 6,500 shares
@ $2.7574, valued at
$17.9k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Sold 8,437 shares
@ $1.7905, valued at
$15.1k
Sold 31,978 shares
@ $1.7727, valued at
$56.7k
|
|
| 06/28/2023 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Sold 1,250,000 shares
@ $46.1, valued at
$57.6M
|
|
| 09/16/2022 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Bought 484,496 shares
@ $10.32, valued at
$5M
|
|
| 07/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Sold 800,000 shares
@ $2, valued at
$1.6M
|
|
| 02/25/2022 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.|
Txns:
| Sold 1,820 shares
@ $2.8997, valued at
$5.3k
Sold 5,990 shares
@ $2.8345, valued at
$17k
Sold 300 shares
@ $2.7032, valued at
$811 |
|
| 02/09/2022 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Converted 3,183,545 shares
@ $0
Bought 833,333 shares
@ $15, valued at
$12.5M
Converted 1,550,309 preferred shares
@ $0
Converted 666,651 preferred shares
@ $0
Converted 533,389 preferred shares
@ $0
Converted 433,196 preferred shares
@ $0 |
|
| 11/10/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on IO Biotech, Inc.|
Txns:
| Converted 2,952,932 shares
@ $0
Bought 325,000 shares
@ $14, valued at
$4.6M
Converted 217,107 convertible preferred
@ $0
Converted 75,267 convertible preferred
@ $0 |
|
| 10/27/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on MINERVA SURGICAL INC|
Txns:
| Converted 884,484 shares
@ $0
Converted 592,648 shares
@ $0
Bought 580,000 shares
@ $12, valued at
$7M
Converted 884,484 options to buy
@ $0
Converted options to buy
@ $0 |
|
| 06/23/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Converted 4,562,636 shares
@ $0
Bought 277,777 shares
@ $18, valued at
$5M
Converted 14,000,000 convertible preferred
@ $0
Converted 1,553,116 convertible preferred
@ $0 |
|
| 06/22/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Converted 443,265 shares
@ $0
Bought 350,000 shares
@ $19, valued at
$6.7M
Converted 443,265 convertible preferred
@ $0 |
|
| 06/03/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Inogen Inc|
Txns:
| Sold 680,000 shares
@ $57.32, valued at
$39M
|
|
| 05/21/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.|
Txns:
| Sold 475,000 shares
@ $13.9, valued at
$6.6M
|
|
| 04/14/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Reneo Pharmaceuticals, Inc.|
Txns:
| Converted 2,763,711 shares
@ $0
Bought 666,666 shares
@ $15, valued at
$10M
Converted 12,367,054 convertible preferred
@ $0 |
|
| 03/31/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Converted 4,962,207 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 2,359,440 convertible preferred
@ $0
Converted 1,952,439 convertible preferred
@ $0
Converted 650,328 convertible preferred
@ $0 |
|
| 03/03/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Inogen Inc|
Txns:
| Sold 790,000 shares
@ $49, valued at
$38.7M
|
|
| 02/19/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Sold 500,000 shares
@ $10.58, valued at
$5.3M
|
|
| 02/11/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Converted 4,027,088 shares
@ $0
Bought 400,000 shares
@ $20, valued at
$8M
Converted 1,096,323 preferred shares
@ $0
Converted 2,050,758 preferred shares
@ $0
Converted 421,670 preferred shares
@ $0
Converted 458,337 preferred shares
@ $0 |
|
| 02/01/2021 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Sold 375,000 shares
@ $21, valued at
$7.9M
|
|
| 11/04/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Galecto, Inc.|
Txns:
| Converted 2,164,458 shares
@ $0
Bought 333,333 shares
@ $15, valued at
$5M
Converted 25,562 preferred shares
@ $0
Converted 15,833 preferred shares
@ $0
Converted 63,333 options to buy
@ $0
Converted 66,666 options to buy
@ $0
Converted 133,991 preferred shares
@ $0
Converted 194,666 preferred shares
@ $0
Converted 181,688 options to buy
@ $0
Converted 51,911 options to buy
@ $0
Converted 98,930 preferred shares
@ $0 |
|
| 10/22/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Eargo, Inc.|
Txns:
| Converted 737,071 shares
@ $0
Bought 150,000 shares
@ $18, valued at
$2.7M
Converted 737,071 convertible preferred
@ $0 |
|
| 10/22/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 2,414,563 shares
@ $0
Bought 200,000 shares
@ $15, valued at
$3M
Converted 1,609,493 convertible preferred
@ $0
Converted 563,851 options to buy
@ $0
Converted 241,219 options to buy
@ $0 |
|
| 10/21/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.|
Txns:
| Converted 2,442,080 shares
@ $0
Converted 4,150,000 options to buy
@ $0
Converted 551,794 options to buy
@ $0
Converted 171,410 options to buy
@ $0
Converted 352,734 options to buy
@ $0 |
|
| 10/19/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Galera Therapeutics, Inc.|
Txns:
| Sold 450,000 shares
@ $11, valued at
$5M
|
|
| 10/16/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.|
Txns:
| Converted 4,739,336 shares
@ $0
Bought 250,000 shares
@ $15, valued at
$3.8M
Converted 21,000,000 convertible preferred
@ $0
Converted 10,000,000 convertible preferred
@ $0 |
|
| 08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Converted 2,194,379 shares
@ $0
Bought 375,000 shares
@ $16, valued at
$6M
Converted 15,000,000 convertible preferred
@ $0
Converted 1,398,600 convertible preferred
@ $0 |
|
| 07/16/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Nkarta, Inc.|
Txns:
| Converted 2,238,310 shares
@ $0
Bought 555,555 shares
@ $18, valued at
$10M
Converted 525,499 convertible preferred
@ $0
Converted 1,712,811 convertible preferred
@ $0 |
|
| 07/09/2020 |
4
| Novo Holdings A/S (10% Owner) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Sold 796,622 shares
@ $5.2514, valued at
$4.2M
Sold 741,440 shares
@ $5.3749, valued at
$4M
|
|
|
|
|